Role of TNF-á in growth, lineage commitment and differentiation of liver progenitor cells

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/513961

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The infection rate of HBV is 20% in Chinese and 10% in Australian in particularly aboriginal. The end-point of this disease is development liver failure and need functional replacement of the liver. Cell therapy represents an alternative of liver transplantation owing to shortage of organ. The information derived from this study is essential for developing strategies to promote growth and differentiation of liver progenitor cell both in vivo and in vitro for therapies to treat liver diseases.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2009

Funding Scheme: Early Career Fellowships

Funding Amount: $228,589.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Sport and exercise nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Hepatitis B | Hepatitis C | Liver progenitor cells | Stem cells | Tissue regeneration

Related Links